Fig. 2From: Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapya Common ligands of BRD4. b Structures and biological activities of PROTACs targeting BRD4. Structures of the E3 ligands are shown in Fig. 1Back to article page